SYED AHSAN: Open Payments
NPI 1033202999 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 25 payments from 10 companies in 2025. Trend: 2023 $189 · 2024 $87 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $316 |
| Brainsway USA INC | 1 | $116 |
| Neurocrine BioSciences, Inc. | 3 | $69 |
| Lundbeck LLC | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Biogen, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| ABBVIE INC. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: COBENFY, deep tms, INGREZZA, REXULTI, ABILIFY MAINTENA, FANAPT, ZURZUVAE, CAPLYTA.
Industry payments across VA — which companies pay providers there.
